About Index Trending news
Lists
Pricing
Nouscom

Nouscom

Nouscom

Nouscom will develop tumor specific oncolytic viruses and patient specific cancer vaccines

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series A)
€12,000,000
Employees

Unknown size

Locations
HQ
Headquarters
€12,000,000 Venture capital (Series A)
FinSMEs

Nouscom Closes €12M in Series A Funding

Health Funding Science